JP2021534253A5 - - Google Patents
Info
- Publication number
- JP2021534253A5 JP2021534253A5 JP2021532537A JP2021532537A JP2021534253A5 JP 2021534253 A5 JP2021534253 A5 JP 2021534253A5 JP 2021532537 A JP2021532537 A JP 2021532537A JP 2021532537 A JP2021532537 A JP 2021532537A JP 2021534253 A5 JP2021534253 A5 JP 2021534253A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- pharmaceutical composition
- composition according
- bendamustine
- organic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024086001A JP2024109878A (ja) | 2018-08-17 | 2024-05-28 | 液体ベンダムスチン医薬組成物 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862764975P | 2018-08-17 | 2018-08-17 | |
| US62/764,975 | 2018-08-17 | ||
| US201862723725P | 2018-08-28 | 2018-08-28 | |
| US62/723,725 | 2018-08-28 | ||
| US201962815376P | 2019-03-08 | 2019-03-08 | |
| US62/815,376 | 2019-03-08 | ||
| PCT/IB2019/056903 WO2020035806A1 (en) | 2018-08-17 | 2019-08-14 | Liquid bendamustine pharmaceutical compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024086001A Division JP2024109878A (ja) | 2018-08-17 | 2024-05-28 | 液体ベンダムスチン医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021534253A JP2021534253A (ja) | 2021-12-09 |
| JP2021534253A5 true JP2021534253A5 (https=) | 2022-08-10 |
Family
ID=69525233
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021532537A Withdrawn JP2021534253A (ja) | 2018-08-17 | 2019-08-14 | 液体ベンダムスチン医薬組成物 |
| JP2024086001A Withdrawn JP2024109878A (ja) | 2018-08-17 | 2024-05-28 | 液体ベンダムスチン医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024086001A Withdrawn JP2024109878A (ja) | 2018-08-17 | 2024-05-28 | 液体ベンダムスチン医薬組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12246007B2 (https=) |
| EP (1) | EP3836921B1 (https=) |
| JP (2) | JP2021534253A (https=) |
| AU (1) | AU2019321089A1 (https=) |
| CA (1) | CA3108321A1 (https=) |
| ES (1) | ES3055021T3 (https=) |
| WO (1) | WO2020035806A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210078505A (ko) | 2018-10-16 | 2021-06-28 | 유에스 나노 푸드 앤 드럭 인코포레이티드 | 종양내 주사 제형 |
| US11730815B2 (en) | 2018-11-26 | 2023-08-22 | Good Health, Llc | Stable liquid pharmaceutical compositions comprising bendamustine |
| WO2021211294A1 (en) * | 2020-04-13 | 2021-10-21 | US Nano Food & Drug INC | Basic chemotherapeutic intratumour injection formulation |
| CA3180338A1 (en) * | 2020-04-15 | 2021-10-21 | Kashiv Biosciences, Llc | Stable ready to dilute formulations of carfilzomib |
| GB202118175D0 (en) | 2021-12-15 | 2022-01-26 | Arecor Ltd | Novel composition |
| US11707450B1 (en) | 2022-03-03 | 2023-07-25 | Slayback Pharma Llc | Stable pharmaceutical compositions of bendamustine |
| CN118415976A (zh) * | 2024-05-09 | 2024-08-02 | 深圳开悦生命科技有限公司 | 多环化合物注射剂及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8436190B2 (en) | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| AR072777A1 (es) | 2008-03-26 | 2010-09-22 | Cephalon Inc | Formas solidas de clorhidrato de bendamustina |
| CA2735899A1 (en) | 2008-09-25 | 2010-04-01 | Cephalon, Inc. | Liquid formulations of bendamustine |
| SMT201700043T1 (it) | 2010-01-28 | 2017-03-08 | Eagle Pharmaceuticals Inc | Formulazioni di bendamustina |
| EP2806872A4 (en) | 2012-01-24 | 2014-12-03 | Innopharma Inc | BENDAMUSTIN COMPOSITIONS AND RELATED METHODS |
| CN104271135B (zh) | 2012-03-20 | 2017-05-17 | 赛多斯有限责任公司 | 在要求减少施用容量的患者中治疗苯达莫司汀响应性状况的方法 |
| JP6250628B2 (ja) | 2012-03-20 | 2017-12-20 | イーグル・ファーマシューティカルズ・インコーポレーテッド | ベンダムスチンの製剤 |
| US20160235717A1 (en) * | 2013-10-11 | 2016-08-18 | Luitpold Pharmaceuticals, Inc. | Bendamustine pharmaceutical compositions |
| WO2016005995A2 (en) | 2014-07-10 | 2016-01-14 | Leiutis Pharmaceuticals Pvt. Ltd. | Glycol free stable liquid compositions of bendamustine |
| WO2016059590A1 (en) | 2014-10-16 | 2016-04-21 | Piramal Enterprises Limited | Stable injectable composition of small molecule drugs and process for its preparation |
| US9603930B2 (en) | 2014-12-04 | 2017-03-28 | Navinta, Llc | Liquid bendamustine formulation |
| CN105726472B (zh) * | 2016-03-25 | 2019-12-13 | 南京康玻斯医药科技有限公司 | 苯达莫司汀药剂组合物及应用 |
| WO2017175098A1 (en) * | 2016-04-05 | 2017-10-12 | Leiutis Pharmaceuticals Pvt Ltd | Stable liquid pharmaceutical formulations of bendamustine |
| US10905677B2 (en) * | 2016-08-31 | 2021-02-02 | Navinta, Llc | Bendamustine solution formulations |
-
2019
- 2019-08-14 EP EP19850670.1A patent/EP3836921B1/en active Active
- 2019-08-14 ES ES19850670T patent/ES3055021T3/es active Active
- 2019-08-14 JP JP2021532537A patent/JP2021534253A/ja not_active Withdrawn
- 2019-08-14 WO PCT/IB2019/056903 patent/WO2020035806A1/en not_active Ceased
- 2019-08-14 AU AU2019321089A patent/AU2019321089A1/en not_active Abandoned
- 2019-08-14 CA CA3108321A patent/CA3108321A1/en active Pending
- 2019-08-14 US US17/268,780 patent/US12246007B2/en active Active
-
2024
- 2024-05-28 JP JP2024086001A patent/JP2024109878A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534253A5 (https=) | ||
| JP6133943B2 (ja) | ベンダムスチンの製剤 | |
| CN104203235B (zh) | 苯达莫司汀的制剂 | |
| JP2015506989A5 (https=) | ||
| CN102164579A (zh) | 苯达莫司汀的液体配制品 | |
| WO2009111057A4 (en) | Fulvestrant formulations | |
| EP2588084B1 (en) | Antibiotic compositions comprising tulathromycin | |
| JP2024109878A (ja) | 液体ベンダムスチン医薬組成物 | |
| US9603930B2 (en) | Liquid bendamustine formulation | |
| AR085273A1 (es) | Formulacion liquida libre de propelente que comprende una droga antimuscarinica | |
| US8809308B2 (en) | Enema composition for treatment of ulcerative colitis having long term stability | |
| WO2017175098A1 (en) | Stable liquid pharmaceutical formulations of bendamustine | |
| US20240009199A1 (en) | Pemetrexed formulations | |
| PE20040303A1 (es) | Formulacion parenteral liquida estable de parecoxib | |
| Kapetanovic et al. | Pharmacokinetics and enhanced bioavailability of candidate cancer preventative agent, SR13668 in dogs and monkeys | |
| JPWO2018056336A1 (ja) | ペメトレキセド製剤 | |
| CN104203224A (zh) | 含有2-氨基-3-(4-溴苯甲酰基)苯乙酸的水性组合物 | |
| JP2017057202A (ja) | ボルテゾミブ含有凍結乾燥医薬組成物およびその製造方法 | |
| US20150320680A1 (en) | Injectable composition containing chlorothiazide | |
| WO2021192471A1 (ja) | ペメトレキセド製剤 | |
| WO2021192472A1 (ja) | ペメトレキセド製剤 | |
| CN105451731A (zh) | 含有经稳定化的2－氨基－3－(4－溴苯甲酰基)苯乙酸的水性组合物 | |
| IL261179A (en) | Pemetrexed formulations | |
| JP2011032220A (ja) | エダラボン液剤 | |
| CN107714651A (zh) | 一种非班太尔脂质体及其制备方法 |